Search - tctmd.com

Displaying 881 - 900 of 2033

Sort: Relevancy | Date

Studies Supporting Device Modifications Weak, Often Based on Surrogate Endpoints

News Daily News

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Michael O'Riordan

August 16, 2017

News Daily News

Stent Fracture, Reintervention Lessened With Prestenting Before Melody Pulmonary Valve Implantation

Yael L. Maxwell

August 16, 2017

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Industry News

AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device

August 08, 2017

News Daily News

Women With A-fib Less Likely to Get Oral Anticoagulants Regardless of Risk

Leah Lawrence

August 03, 2017

News Industry News

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

August 01, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 27, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 26, 2017

News Industry News

Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent

July 25, 2017

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Shelley Wood

July 21, 2017

News Industry News

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

July 20, 2017

News Daily News

Dabigatran Reversal Agent Yields No Surprises in Final RE-VERSE AD Study Results

Todd Neale

July 14, 2017

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Daily News

Betrixaban Approved for Prevention of VTE

Michael O'Riordan

June 23, 2017

News Daily News

‘Mishmash’ of Troponin Cutoffs Being Used to Diagnose MI

Todd Neale

June 23, 2017

News Daily News

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Michael O'Riordan

June 22, 2017

News Industry News

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

June 22, 2017

News Features

Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions?

Todd Neale

June 21, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Advertisement

FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints

Stent Fracture, Reintervention Lessened With Prestenting Before Melody Pulmonary Valve Implantation

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device

Women With A-fib Less Likely to Get Oral Anticoagulants Regardless of Risk

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Abbott Initiates Clinical Trial of Three-Month Dual Antiplatelet Therapy Following Implantation with XIENCE Coronary Stent

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

Dabigatran Reversal Agent Yields No Surprises in Final RE-VERSE AD Study Results

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Betrixaban Approved for Prevention of VTE

‘Mishmash’ of Troponin Cutoffs Being Used to Diagnose MI

One in 10 TAVR Patients Treated Off-Label: TVT Registry

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions?

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content